MedTrace Logo

Maternal Oxygen Administration for Fetal Distress

NCT02221440 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 443

Last updated 2020-05-26

No results posted yet for this study

Summary

Supplementary oxygen is routinely administered to patients, even those with adequate oxygen saturations, in the belief that it increases oxygen delivery. However, oxygen delivery depends not just on arterial oxygen content but also on perfusion.

Maternal oxygen administration has been used in an attempt to lessen fetal distress by increasing the available oxygen from the mother. However, the effect of supplemental maternal oxygen therapy on fetal acid base status has been debated for more than seven decades.

Hypothesis: Prophylactic maternal low flow nasal oxygen administration during the second stage of labor can relieve fetal distress.

Conditions

  • Oxygen Inhalation Therapy
  • Second Stage of Labour
  • Fetal Distress

Interventions

DEVICE

Low flow nasal oxygen

Oxygen will be administered by nasal catheter at a flow rate of 2 L/min. The therapy will continue until after delivery

DEVICE

Low flow room air

Sham: oxygen will be administered by nasal catheter at a flow rate of 0 L/min.

Sponsors & Collaborators

  • Navy General Hospital, Beijing

    lead OTHER

Principal Investigators

  • Yunhai Chuai, Dr · Navy General Hospital, Beijing

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02221440 on ClinicalTrials.gov